“Right-wing doctors are still peddling dubious COVID drugs.”
Pharmaceuticals
Posted inHighlight, Nonfiction, Quote Posts, Quotes
Health Care Sponcon: Where Big Pharma Meets Instagram Influencer
Health care and medical sponsored content from influencers is growing on Instagram. But is it ethical?
Posted inEditor's Pick
The latest Instagram influencer frontier? Medical promotions.
Health care and medical sponsored content from influencers is growing on Instagram. But is it ethical?
Posted inBusiness & Tech, Nonfiction, Quotes, Science & Nature
The Sacred Right of Universal Narcotic Entitlement
Inventing maladies and marketing drugs to relieve them isn’t a new m.o. for pharmaceutical companies. OxyContin is its fullest and most terrible expression.
Posted inEditor's Pick
The Secretive Family Making Billions From the Opioid Crisis
Do you know that the company that makes OxyContin and reaps the billions of dollars in profits it generates is owned by one family?
Posted inNonfiction, Quotes, Science & Nature
The Pitfalls and Promise of the Horseshoe Crab, Unlikely Biomedical Hero
Pharmaceutical companies catch half a million horseshoe crabs a year to drain their blood for medical use. But is this practice sustainable?
Posted inNonfiction, Reading List
The Dark Arts: A Corporate Espionage Reading List
Corporate espionage takes many forms and is known by a number of names. At its most benign, it’s “competitive-intelligence,” which is the kind of information gathering that George Chidi describes in Inc. On the other end of the spectrum is the far more exciting—and illicit—line of work seen in Richard Behar’s 1999 story about the pharmaceutical industry. Here are five stories that delve deep into the murky world of corporate information gathering.
Posted inNonfiction, Reading List
The Dark Arts: A Corporate Espionage Reading List
Corporate espionage takes many forms and is known by a number of names. At its most benign, it’s “competitive-intelligence,” which is the kind of information gathering that George Chidi describes in Inc. On the other end of the spectrum is the far more exciting—and illicit—line of work seen in Richard Behar’s 1999 story about the pharmaceutical industry. Here are five stories that delve deep into the murky world of corporate information gathering.